查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1922905

床邊尿袋市場按產品類型、材質類型、最終用戶和分銷管道分類－2026-2032年全球預測

Bedside Urine Bag Market by Product Type, Material Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，床邊尿袋市場價值將達到 20.1 億美元，到 2026 年將成長至 21.4 億美元，到 2032 年將達到 35.6 億美元，複合年成長率為 8.52%。

關鍵市場統計數據
基準年 2025 20.1億美元
預計年份：2026年 21.4億美元
預測年份 2032 35.6億美元
複合年成長率 (%) 8.52%

這是一份簡潔的策略性介紹，闡述了臨床需求、材料選擇和不斷發展的護理模式如何重新定義床邊尿袋採購者的優先事項。

床邊尿袋是患者照護和居家照護中普遍存在卻又常常被忽視的要素，在病患監測、感染預防和工作流程效率方面發揮著至關重要的作用。臨床醫生依賴設備的可靠性和明確的測量功能來指導液體管理決策。同時，採購團隊在製定合約時需要權衡成本、供應連續性和法規遵循。近年來，隨著醫療服務模式的轉變以及技術的進步，人們開始重新評估產品規格、材料選擇和分銷模式。出於對病人安全的考慮，例如減少導尿管相關尿道感染和改善人體工學，人們更加重視產品設計和臨床醫生培訓。同時，居家醫療和遠端監測的興起也改變了人們對便攜性、一次性使用性和連接性的要求。了解臨床需求、材料科學、法規要求和通路之間的相互作用，是製定可行策略的基礎。本文提供了一個分析框架，將床旁尿袋置於臨床效用、供應鏈韌性和產品創新三者的交匯點上進行探討。這為評估產品系列、夥伴關係和投資重點的相關人員設定了預期。

數位連結、永續材料趨勢和分銷創新如何融合，從根本上重塑產品設計和籌資策略

床邊尿袋市場格局正經歷變革，其驅動力包括醫療數位化、永續性以及不斷演變的供應鏈。在某些醫療環境中，醫療設備互聯已不再是新鮮事物，而是營運的必要條件。物聯網尿液計量器可遠端監測，將數據整合到電子健康記錄中，從而能夠及早識別患者病情惡化。與技術進步同步，日益嚴格的監管審查和採購政策的轉變，促使人們關注非聚氯乙烯（PVC）材料，例如生物基聚合物和熱可塑性橡膠，這些材料可減少長期環境影響，並支持醫院的永續性目標。隨著電子商務和直接面向製造商通路的擴張，分銷模式也在重組，實現了快速補貨和多樣化的定價結構，這對傳統的全國性和區域分銷商模式提出了新的挑戰。居家醫療的成長和遠端監測服務的擴展，進一步推動了產品在非急性環境下的便攜性、易用性和經臨床醫生檢驗的準確性方面的重新設計。因此，策略重點正從單純的單位成本最佳化轉向「總醫療成本」概念，涵蓋設備生命週期、感染控制性能和數據驅動的臨床價值。這些複雜的變化要求製造商和供應商合作夥伴協調產品創新、法規遵循和分銷策略，以保持競爭力並滿足臨床需求。

評估2025年關稅對醫院尿袋相關人員供應鏈、採購和採購策略的系統性影響

計劃於2025年實施的進口醫療設備組件和聚合物新關稅，正促使各機構重新評估籌資策略和供應鏈結構。關稅導致投入成本增加，促使企業更加重視供應商多元化、關鍵組件的近岸生產以及重新談判長期契約，以保障利潤率並確保業務連續性。為此，一些製造商正在尋找替代材料，並在法規和性能允許的情況下加快採用生物基聚合物和熱可塑性橡膠。醫院和集團採購組織正在將物流成本、海關延誤和庫存持有成本納入採購決策，並更嚴格地審查總到岸成本。關稅也促使國內製造地加大對流程最佳化和自動化方面的投資，以在保持具有競爭力的前置作業時間的同時緩解成本壓力。通路也受到影響，區域分銷商和全國供應鏈正在重新評估定價結構，並利用電子商務和直接面向製造商的模式來繞過部分中間商利潤。臨床醫生和採購團隊需要在熟悉現有產品和快速更換供應商帶來的營運風險之間權衡取捨。最終，關稅的累積影響已將供應鏈風險管理、材料多功能性和合約柔軟性提升為製造商、供應鏈合作夥伴和醫療系統採購領導者必須關注的策略問題。

深入的細分市場分析揭示了終端用戶環境、產品創新、通路和材料選擇如何驅動差異化產品和市場推廣策略的發展。

細分市場趨勢揭示了不同的需求促進因素和設計重點，產業相關人員應將這些因素納入其產品藍圖和市場推廣計畫。按最終用戶分類，門診手術中心和診所優先考慮緊湊、易於儲存的解決方案，以滿足周轉率和感染控制要求。醫院則尋求可擴展的庫存管理和高吞吐量的符合人體工學的設計，用於集中監測。隨著遠端監測服務的擴展，居家醫療越來越需要便攜性和簡化的使用者介面。依產品類型分類，防回流尿袋強調安全性和閥門可靠性，以保障弱勢患者族群的需求。標準尿袋有雙隔間和單隔間兩種配置，兼顧成本和性能，以滿足不同的尿量測量需求。尿量計分為適用於既定臨床工作流程的傳統類型和支援物聯網的尿量計，後者增加了連接性和分析功能，可用於更進階的監測。按分銷管道分類，醫院藥房在大量採購中仍發揮核心作用。同時，醫療設備批發商在國家和地區層面運營，提供豐富的選擇和本地化的物流支援。包括電商平台和廠商直銷在內的線上銷售管道正在重塑補貨週期和價格透明度。零售藥局也積極拓展門診和居家醫療等細分市場。就材料類型而言，聚氯乙烯（PVC）因其成本效益和成熟的加工過程而仍被廣泛使用。同時，生物基聚合物和熱可塑性橡膠等非PVC替代品因其更優異的環境性能和合規性而備受關注。總而言之，這些細分觀點指南研發、臨床檢驗和商業投資的重點，以滿足特定臨床環境和產品偏好的需求。

區域趨勢和監管差異（美洲、歐洲、中東和非洲、亞太地區）需要量身定做的商業性、監管和生產應對措施。

區域趨勢導致監管、採購和實施模式存在顯著差異，要求製造商和經銷商採取量身定做的策略。在美洲，醫療系統優先考慮規模、與整合電子健康記錄的兼容性以及評估供應商可靠性和臨床證據的採購協議。無論是私人還是公共支付方，都越來越關注基於價值的結果，鼓勵採用能夠減少併發症和提高工作流程效率的解決方案。在歐洲、中東和非洲，複雜的法規環境和多樣化的採購模式尤其重視本地監管專業知識、靈活的分銷網路以及對區域環境指令的嚴格遵守。該地區小規模的市場可以率先在私人醫療機構中採用永續材料和物聯網測量技術。在亞太地區，醫院容量的快速擴張、對居家醫療需求的成長以及對數位醫療基礎設施的投資，為擴充性的解決方案創造了機遇，包括低成本、堅固耐用的解決方案以及高所得都市區更先進的物聯網解決方案。無論在哪個地區，關稅政策、物流複雜性和本地製造能力都會影響近岸外包、經銷商合作關係和服務模式的決策。針對這些區域差異調整產品特性、監管文件和商業性策略，對於持續推廣和提高營運效率至關重要。

關鍵的競爭與夥伴關係洞察，揭示了產品差異化、供應鏈韌性和分銷策略如何決定供應商的吸引力和成長潛力。

床邊尿袋市場的競爭格局由成熟製造商、創新醫療技術公司和專業本地供應商組成。領先企業透過持續投資臨床檢驗、產品人體工學和供應鏈韌性來脫穎而出，而新參與企業則尋求透過整合互聯功能、永續材料或精益分銷模式來加快產品交付速度。醫療設備製造商和醫院技術團隊之間正在建立策略聯盟，以試點支援物聯網的尿液計量器和遠端監測工作流程，這些聯盟通常輔以針對性的臨床醫生培訓和數據整合工作。擁有多元化全球製造地和冗餘供應商網路的製造商展現出應對關稅和物流中斷的韌性，而依賴單一來源聚合物的公司則面臨更大的風險。分銷策略正在多元化發展，一些公司加強了傳統的全國性和區域分銷商網路以維持服務覆蓋範圍，而另一些公司則拓展了製造商直銷管道和電子商務，以提高利潤率和應對力。併購和聯盟的重點在於擴展產品組合，以滿足不同的終端用戶需求，例如增加回流防止設計、雙腔解決方案和數位化測量功能。監管合規記錄、品質系統成熟度和透明的供應連續性計畫正成為買家和合作夥伴評估潛在供應商的關鍵選擇標準。

產業領導者現在必須採取切實可行的策略步驟，以加強價值鏈、加速高價值創新並重塑分銷和臨床合作模式。

產業領導者可以即時採取切實可行的措施來保護利潤率，加速推廣高價值產品，並增強應對監管和貿易逆風的能力。優先考慮關鍵聚合物原料的供應商多元化和近岸外包方案，同時投資於生物基聚合物和熱可塑性橡膠等替代材料，以降低關稅帶來的成本壓力。加速物聯網尿流率計的開發和臨床檢驗，在遠端監測和數據整合能夠帶來可衡量的工作流程改善和臨床效益的環境中創造價值。透過試點廠商直銷和選擇性電子商務項目來重組分銷策略，以提高補貨速度和價格透明度，並與國家和地區分銷商協商靈活的契約，使獎勵與服務水平達成協議保持一致。積極與醫療系統採購和臨床團隊合作，將產品規格與總醫療成本結果掛鉤，尤其要利用能夠減少併發症和護理時間的針對性試點研究。最後，將情境規劃融入商業策略，為因應未來的政策變化做好準備。這包括對物流計劃進行壓力測試，並為高利用率設施維持緩衝庫存。這些措施結合起來，可以增強您的競爭優勢，並使您的組織能夠抓住新的需求領域。

我們採用透明的檢驗調查方法，結合關鍵相關人員訪談、監管和文件分析、供應鏈映射以及專家同行評審，以得出可靠的結論。

本分析整合了透過結構化且透明的調查方法收集的定性和定量證據，該方法優先考慮可靠性和三角驗證。主要研究包括對醫院、門診診所和居家醫療機構的臨床醫生、採購經理、分銷公司高管和醫療設備工程師進行結構化訪談，以了解實際環境中的設備性能標準、採購決策促進因素和物流限制。次要研究包括分析監管文件、導管相關感染預防的臨床指南、聚合物和生物基替代品的材料科學文獻，以及與製造地和產能相關的公開文件。供應鏈圖譜確定了聚合物原料、組裝製程和分銷點的關鍵節點，專利格局分析和產品規格審查則描述了創新軌跡。數據整合應用了交叉檢驗技術來協調不同相關人員的觀點，並對分析中引用的所有文件進行了專家同行評審和資訊來源檢驗，作為品質保證流程。考慮到由於供應商專有協議和快速變化的關稅政策而導致的完全透明性方面的局限性，我們進行了敏感性分析，以評估我們在多種營運情境下策略結論的穩健性。

本文概述了在日益成長的臨床期望和政策壓力下，整合產品、供應鏈和商業策略將如何決定主導地位。

床邊尿袋產業正處於轉折點，臨床需求、永續性目標和貿易政策在此交匯，既帶來風險也帶來機會。技術應用，特別是物聯網賦能的監測，正在為急診和居家照護開闢新的臨床價值途徑，而材料創新則為應對環境和監管壓力提供了有希望的方案。關稅趨勢凸顯了供應商多元化、生產彈性和合約柔軟性的重要性，而那些積極整合銷售管道和數位補貨的商業模式的經銷商和製造商將獲得競爭優勢。此外，按最終用戶、產品類型、分銷管道和材料進行細分意味著「一刀切」的方法越來越難以奏效；相反，有針對性的產品差異化和地理市場策略至關重要。積極投資於臨床檢驗、供應鏈韌性和與醫療保健系統建立合作夥伴關係的相關人員將最有能力將這些趨勢轉化為永續成長。簡而言之，將循證產品開發與適應性供應和商業策略相結合，將決定哪些公司能夠在床邊尿袋發展的下一階段蓬勃發展。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 床邊尿袋市場依產品類型分類

  • 防逆流尿袋
  • 標準尿袋
    • 雙腔型
    • 單室
  • 尿量計
    • 傳統尿量計
    • 相容物聯網的尿量計

9. 依材質類型分類的床邊尿袋市場

  • 非氯乙烯
    • 生物基聚合物
    • 熱可塑性橡膠
  • 聚氯乙烯

第10章 床邊尿袋市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 居家醫療
  • 醫院

第11章 依分銷管道分類的床邊尿袋市場

  • 醫院藥房
  • 醫療批發商
    • 全國批發商
    • 區域批發商
  • 線上銷售
    • 電子商務平台
    • 直接從製造商購買
  • 零售藥房

第12章 各地區床邊尿袋市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 床邊尿袋市場（依族群分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國床邊尿袋市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國床邊尿袋市場

第16章 中國床邊尿袋市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • Crucial Medical Supply
  • Fresenius Kabi AG
  • Halyard Health
  • Hollister Incorporated
  • Lohmann & Rauscher International GmbH & Co. KG
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Nipro Corporation
  • Pelican Healthcare Ltd.
  • Smiths Group plc
  • Teleflex Incorporated
  • UXL Medical Limited
Product Code: MRR-867BED9A9E47

The Bedside Urine Bag Market was valued at USD 2.01 billion in 2025 and is projected to grow to USD 2.14 billion in 2026, with a CAGR of 8.52%, reaching USD 3.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.01 billion
Estimated Year [2026] USD 2.14 billion
Forecast Year [2032] USD 3.56 billion
CAGR (%) 8.52%

A concise strategic introduction explaining how clinical needs, material choices, and evolving care models are redefining bedside urine bag priorities for purchasers

The bedside urine bag remains a ubiquitous but often underexamined component of inpatient and home-based care delivery, serving a critical role in patient monitoring, infection prevention, and workflow efficiency. Clinicians rely on device reliability and clear measurement capability to inform fluid management decisions, while procurement teams balance cost, supply continuity, and regulatory compliance when defining contracts. Recent years have seen incremental technological advancements alongside changing care delivery patterns, prompting a reassessment of product specifications, material selection, and distribution models. Patient safety concerns, including catheter-associated urinary tract infection reduction and improved handling ergonomics, have placed greater emphasis on product design and clinician training. At the same time, the rise of home healthcare and remote monitoring is altering specifications for portability, disposability, and connectivity. Understanding these intersecting forces-clinical requirements, materials science, regulatory imperatives, and distribution pathways-creates the foundation for actionable strategy. This introduction frames the remainder of the analysis by situating bedside urine bags at the nexus of clinical utility, supply chain resilience, and product innovation, and sets expectations for stakeholders evaluating product portfolios, partnerships, and investment priorities.

How digital connectivity, sustainable material trends, and distribution innovations are converging to fundamentally reshape product design and procurement strategies

The landscape for bedside urine bags is undergoing transformative shifts driven by digitization of care, sustainability imperatives, and evolving channels of delivery. Device connectivity has moved beyond novelty to operational necessity in some care settings, with IoT-enabled urimeters enabling remote monitoring, data integration into electronic health records, and early recognition of patient deterioration. Parallel to technological advances, regulatory scrutiny and procurement preferences are accelerating interest in non-PVC materials, including bio-based polymers and thermoplastic elastomers, which reduce long-term environmental liabilities and support hospital sustainability goals. Distribution is also being reshaped as e-commerce and manufacturer-direct channels expand, offering faster replenishment and alternative pricing structures that challenge traditional national and regional distributor models. Home healthcare growth and the expansion of remote monitoring services are further prompting product redesign for portability, simplified use, and clinician-validated accuracy outside acute settings. Consequently, strategic priorities are shifting from pure unit-cost optimization to total-cost-of-care thinking that incorporates device lifecycle, infection control performance, and data-enabled clinical value. These combined shifts require manufacturers and supply partners to coordinate product innovation, regulatory engagement, and distribution strategies to remain competitive and clinically relevant.

Assessing the systemic implications of 2025 tariff measures on supply chains, material sourcing, and procurement strategy for bedside urine bag stakeholders

The introduction of new tariffs in 2025 affecting medical device components and polymer imports has prompted organizations to reassess sourcing strategies and supply chain architectures for bedside urine bags. Tariff-driven input cost inflation has placed renewed emphasis on supplier diversification, nearshoring of key components, and renegotiation of long-term agreements to protect margins and ensure continuity. In response, some manufacturers have shifted procurement toward alternative feedstocks, accelerating adoption of bio-based polymers and thermoplastic elastomers where regulatory and performance profiles allow. Hospitals and group purchasing organizations have increased scrutiny of total landed costs, factoring logistics, customs clearance delays, and inventory carrying costs into procurement decisions. Tariffs have also spurred investment in process optimization and automation in domestic manufacturing footprints to absorb cost pressure while maintaining competitive lead times. Distribution channels have been affected as well; regional distributors and national supply chains have had to revise pricing frameworks, while e-commerce and manufacturer-direct sales models have been leveraged to bypass some intermediary markups. Clinicians and procurement teams face the trade-off between established product familiarity and the operational risk associated with rapid supplier changes. Ultimately, the cumulative impact of tariffs has elevated supply chain risk management, material versatility, and contractual flexibility as strategic imperatives for manufacturers, supply chain partners, and health system procurement leaders alike.

In-depth segmentation analysis revealing how end-user settings, product innovations, distribution pathways, and material choices determine differentiated product and go-to-market priorities

Segment-specific dynamics reveal differentiated demand drivers and design priorities that industry players must integrate into product roadmaps and go-to-market plans. Based on end user, ambulatory surgical centers and clinics prioritize compact, easy-to-store solutions that support turnover and infection control requirements, hospitals demand scalable inventory and high-throughput ergonomics for intensive monitoring, and home healthcare increasingly requires portability and simplified user interfaces, particularly as remote monitoring services expand. Based on product type, anti-reflux urine bags emphasize patient safety and valve reliability for vulnerable populations, standard urine bags balance cost and performance across dual chamber and single chamber configurations to suit varying drainage and measurement needs, and urimeters split into conventional units favored for established clinical workflows and IoT-enabled urimeters that add connectivity and analytics for higher-acuity surveillance. Based on distribution channel, hospital pharmacies remain central to bundled procurement, while medical distributors operate at national and regional levels to provide breadth and localized logistics support; online sales channels including e-commerce platforms and manufacturer direct sales are reshaping replenishment cadence and price transparency, and retail pharmacies serve niche ambulatory and home settings. Based on material type, polyvinyl chloride continues to be widely used for its cost-effectiveness and established processing pathways even as non-polyvinyl chloride alternatives such as bio-based polymers and thermoplastic elastomers attract attention for improved environmental profiles and regulatory alignment. These segmentation lenses collectively guide where to focus R&D, clinical validation, and commercial investment to capture demand across care settings and product preferences.

Regional dynamics and regulatory distinctions across the Americas, Europe Middle East & Africa, and Asia-Pacific that require tailored commercial, regulatory, and manufacturing approaches

Regional dynamics create distinct regulatory, procurement, and adoption patterns that manufacturers and distributors must navigate with tailored strategies. In the Americas, health systems emphasize scale, integrated electronic health record compatibility, and purchasing contracts that reward supplier reliability and clinical evidence; private and public payers alike are increasingly focused on value-based outcomes, encouraging solutions that demonstrate reduced complications and improved workflow efficiency. In Europe, Middle East & Africa, the regulatory mosaic and diverse procurement models place a premium on local regulatory expertise, flexible distribution networks, and material compliance with regional environmental directives; smaller market pockets within the region can act as early adopters for sustainable materials or IoT-enabled measurement in private care facilities. In Asia-Pacific, rapid expansion of hospital capacity, strong home healthcare demand, and investments in digital health infrastructure create opportunities for scalable solutions, particularly for low-cost, robust designs alongside more advanced IoT offerings in higher-income urban centers. Across regions, tariff policies, logistics complexity, and local manufacturing capacity shape decisions about nearshoring, distributor partnerships, and service models. Tailoring product features, regulatory submissions, and commercial approaches to these regional nuances is essential for sustained uptake and operational efficiency.

Key competitive and partnership insights that reveal how product differentiation, supply chain resilience, and distribution strategies determine supplier attractiveness and growth potential

Competitive dynamics in the bedside urine bag space are being shaped by a mix of incumbent manufacturers, innovative medtech firms, and specialized local suppliers. Leading players differentiate through sustained investment in clinical validation, product ergonomics, and supply chain resilience, while challengers seek advantage by integrating connectivity, sustainable materials, or lean distribution models that reduce time-to-consumer. Strategic partnerships between device manufacturers and health system technology teams have emerged to pilot IoT-enabled urimeters and remote monitoring workflows, often supported by targeted clinician training and data integration efforts. Manufacturers with diversified global manufacturing footprints and redundant supplier networks have exhibited greater resilience to tariff and logistics shocks, whereas companies reliant on single-source polymer supplies face elevated risk. Distribution strategies vary: some firms double down on traditional national and regional distributor networks to maintain service coverage, while others scale manufacturer-direct channels and e-commerce to improve margins and responsiveness. Mergers and alliances have centered on broadening portfolios-adding anti-reflux designs, dual-chamber solutions, or digital measurement capabilities-to meet differentiated end-user requirements. For purchasers and partners assessing potential suppliers, evidence of regulatory compliance, quality systems maturity, and transparent supply continuity planning are becoming primary selection criteria.

Actionable strategic steps industry leaders should implement now to shore up supply chains, accelerate high-value innovations, and realign distribution and clinical engagement models

Industry leaders can take immediate, actionable steps to protect margins, accelerate adoption of higher-value products, and strengthen resilience in the face of regulatory and trade headwinds. Prioritize supplier diversification and nearshoring options for critical polymer inputs while simultaneously investing in material substitution pathways such as bio-based polymers and thermoplastic elastomers to reduce exposure to tariff-induced cost pressure. Accelerate development and clinical validation of IoT-enabled urimeters to capture value in settings where remote monitoring and data integration deliver measurable workflow or clinical benefits. Reconfigure distribution strategies by piloting manufacturer-direct replenishment or selective e-commerce programs to improve replenishment speed and pricing transparency, and negotiate flexible contracts with national and regional distributors that align incentives for service-level performance. Engage proactively with health system procurement and clinical teams to link product specifications to total cost of care outcomes, using targeted pilot studies to demonstrate reductions in complications or nursing time. Finally, integrate scenario-based planning into commercial strategy to prepare for further policy shifts, including stress-testing logistics plans and maintaining buffer inventories for high-use facilities. These measures can collectively enhance competitiveness and position organizations to capitalize on emerging demand segments.

A transparent, triangulated research methodology combining primary stakeholder interviews, regulatory and materials analysis, supply chain mapping, and expert peer review to ensure robust conclusions

This analysis synthesizes qualitative and quantitative evidence gathered through a structured and transparent research methodology that prioritizes reliability and triangulation. Primary research included structured interviews with clinicians across hospital, ambulatory, and home healthcare settings, procurement managers, distributor executives, and device engineers to capture real-world device performance criteria, purchasing triggers, and logistical constraints. Secondary research comprised regulatory documentation, clinical guidelines related to catheter-associated infection prevention, materials science literature on polymers and bio-based alternatives, and public filings pertinent to manufacturing footprints and capacity. Supply chain mapping identified key nodes for polymer feedstocks, assembly operations, and distribution hubs, while patent landscaping and product specification reviews were used to characterize innovation trajectories. Data synthesis applied cross-validation techniques to reconcile differing stakeholder perspectives, and quality assurance steps included expert peer review and source verification for all material cited in the analysis. Limitations are acknowledged where proprietary supplier agreements or rapidly evolving tariff policies restrict full transparency, and sensitivity checks were used to evaluate the robustness of strategic conclusions under multiple operational scenarios.

Concluding synthesis on how integrated product, supply chain, and commercial strategies will determine leading positions as clinical expectations and policy pressures intensify

The bedside urine bag sector stands at an inflection point where clinical expectations, sustainability goals, and trade policy converge to create both risk and opportunity. Technological adoption, particularly IoT-enabled monitoring, is unlocking new pathways to clinical value in acute and home care, while material innovation offers a credible response to environmental and regulatory pressures. Tariff dynamics have highlighted the importance of supplier diversification, manufacturing agility, and contracting flexibility, and distributors and manufacturers that adapt their commercial models to embrace direct channels and digital replenishment will gain competitive advantage. Moreover, segmentation across end users, product types, distribution channels, and materials underscores that one-size-fits-all approaches are increasingly untenable; instead, targeted product differentiation and regional market strategies are essential. Stakeholders who proactively invest in clinical validation, supply chain resilience, and collaborative partnerships with health systems will be best positioned to convert these trends into sustainable growth. In short, integrating evidence-based product development with adaptive supply and commercial strategies will determine who thrives in the next phase of bedside urine bag evolution.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bedside Urine Bag Market, by Product Type

  • 8.1. Anti-Reflux Urine Bag
  • 8.2. Standard Urine Bag
    • 8.2.1. Dual Chamber
    • 8.2.2. Single Chamber
  • 8.3. Urimeter
    • 8.3.1. Conventional Urimeter
    • 8.3.2. Iot-Enabled Urimeter

9. Bedside Urine Bag Market, by Material Type

  • 9.1. Non-Polyvinyl Chloride
    • 9.1.1. Bio-Based Polymers
    • 9.1.2. Thermoplastic Elastomer
  • 9.2. Polyvinyl Chloride

10. Bedside Urine Bag Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Clinics
  • 10.3. Home Healthcare
  • 10.4. Hospitals

11. Bedside Urine Bag Market, by Distribution Channel

  • 11.1. Hospital Pharmacy
  • 11.2. Medical Distributors
    • 11.2.1. National Distributors
    • 11.2.2. Regional Distributors
  • 11.3. Online Sales
    • 11.3.1. E-Commerce Platforms
    • 11.3.2. Manufacturer Direct Sales
  • 11.4. Retail Pharmacy

12. Bedside Urine Bag Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bedside Urine Bag Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bedside Urine Bag Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Bedside Urine Bag Market

16. China Bedside Urine Bag Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. B. Braun Melsungen AG
  • 17.7. Baxter International Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Cardinal Health, Inc.
  • 17.10. Coloplast A/S
  • 17.11. ConvaTec Group PLC
  • 17.12. Crucial Medical Supply
  • 17.13. Fresenius Kabi AG
  • 17.14. Halyard Health
  • 17.15. Hollister Incorporated
  • 17.16. Lohmann & Rauscher International GmbH & Co. KG
  • 17.17. Medline Industries, LP
  • 17.18. Molnlycke Health Care AB
  • 17.19. Nipro Corporation
  • 17.20. Pelican Healthcare Ltd.
  • 17.21. Smiths Group plc
  • 17.22. Teleflex Incorporated
  • 17.23. UXL Medical Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BEDSIDE URINE BAG MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BEDSIDE URINE BAG MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ANTI-REFLUX URINE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ANTI-REFLUX URINE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ANTI-REFLUX URINE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DUAL CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DUAL CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DUAL CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CONVENTIONAL URIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CONVENTIONAL URIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CONVENTIONAL URIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY IOT-ENABLED URIMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY IOT-ENABLED URIMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY IOT-ENABLED URIMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY BIO-BASED POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY THERMOPLASTIC ELASTOMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY MANUFACTURER DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BEDSIDE URINE BAG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA BEDSIDE URINE BAG MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA BEDSIDE URINE BAG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA BEDSIDE URINE BAG MARKET SIZE, BY STANDARD URINE BAG, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA BEDSIDE URINE BAG MARKET SIZE, BY URIMETER, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA BEDSIDE URINE BAG MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA BEDSIDE URINE BAG MARKET SIZE, BY NON-POLYVINYL CHLORIDE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA BEDSIDE URINE BAG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA BEDSIDE URINE BAG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA BEDSIDE URINE BAG MARKET SIZE, BY MEDICAL DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA BEDSIDE URINE BAG MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)